p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance.
Zhang J, Tan P, Guo L, Gong J, Ma J, Li J, Lee M, Fang S, Jing J, Johnson G, Sun D, Cao WM, Dashwood R, Han L, Zhou Y, Dong WG, Huang Y.
Zhang J, et al. Among authors: lee m.
Oncogene. 2019 Mar;38(11):1905-1919. doi: 10.1038/s41388-018-0524-5. Epub 2018 Nov 2.
Oncogene. 2019.
PMID: 30390073
Free PMC article.